PFM Health Sciences’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-82,952
| Closed | -$3.18M | – | 75 |
|
|
2024
Q2 | $3.18M | Hold |
82,952
| – | – | 0.16% | 57 |
|
|
2024
Q1 | $4.88M | Buy |
+82,952
| New | +$4.88M | 0.23% | 64 |
|
|
2023
Q3 | – | Sell |
-274,498
| Closed | -$25M | – | 71 |
|
|
2023
Q2 | $25M | Sell |
274,498
-9,771
| -3% | -$890K | 0.97% | 41 |
|
|
2023
Q1 | $18.8M | Sell |
284,269
-34,153
| -11% | -$2.25M | 0.83% | 43 |
|
|
2022
Q4 | $16.5M | Buy |
318,422
+196,542
| +161% | +$10.2M | 0.59% | 48 |
|
|
2022
Q3 | $8.32M | Buy |
+121,880
| New | +$8.32M | 0.3% | 64 |
|